Biocon’s shares surged over 7% on January 14, 2025, after HSBC upgraded its rating to ’Buy’ with a target price of ₹430, ...

HSBC's base case target suggests 10 per cent upside over the prevailing stock price. Its bull case target suggests 40 per ...

The Nifty50 had a gap-up opening at 23,216.50 on Tuesday and ended the day at 23,176.05, up 0.39% from Monday's close.

The Indian market is expected to trade higher on January 15, supported by positive global cues. Nifty futures gained 0.51% on ...

Indus Towers, Biocon and JM Financial are among top stocks to buy today for intraday trade. Besides, IRFC shares will also ...

Indian stock market rebounded on January 14, marking a recovery after four consecutive sessions of selling pressure that had ...

The market is expected to consolidate until it gets back above all key moving averages. Below are some trading ideas for the ...

Biocon Ltd. key Products/Revenue Segments include Bio Pharmaceuticals, Other Operating Revenue, Waste and Sale of services for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company ...

This episode of "Two Sharp with ET" covers three key developments. After consecutive losses, Sensex finally breaks its losing streak, closing in the green. Midcaps see strong buying, led by PSU Banks, ...

Indian benchmark indices Nifty 50 and Sensex ended the previous trade session nearly 1.5% lower each. Nifty 50 closed at ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...